These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Update on pathogenesis, management, and control of Plasmodium vivax. Khan N; Daily JP Curr Opin Infect Dis; 2022 Oct; 35(5):404-409. PubMed ID: 36066361 [TBL] [Abstract][Full Text] [Related]
10. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Mueller I; Galinski MR; Baird JK; Carlton JM; Kochar DK; Alonso PL; del Portillo HA Lancet Infect Dis; 2009 Sep; 9(9):555-66. PubMed ID: 19695492 [TBL] [Abstract][Full Text] [Related]
11. [Atypical forms of Plasmodium vivax. Apropos of a case]. Poirriez J; Landau I; Verhaeghe A; Savage A; Dei-Cas E Ann Parasitol Hum Comp; 1991; 66(4):149-54. PubMed ID: 1789678 [TBL] [Abstract][Full Text] [Related]
12. Plasmodium vivax in Hematopoietic Niches: Hidden and Dangerous. Silva-Filho JL; Lacerda MVG; Recker M; Wassmer SC; Marti M; Costa FTM Trends Parasitol; 2020 May; 36(5):447-458. PubMed ID: 32298632 [TBL] [Abstract][Full Text] [Related]
13. Reticulocyte-prone malaria parasites predominantly invade CD71hi immature cells: implications for the development of an in vitro culture for Plasmodium vivax. Martín-Jaular L; Elizalde-Torrent A; Thomson-Luque R; Ferrer M; Segovia JC; Herreros-Aviles E; Fernández-Becerra C; Del Portillo HA Malar J; 2013 Dec; 12():434. PubMed ID: 24289105 [TBL] [Abstract][Full Text] [Related]
14. Haematological response in experimental human Plasmodium falciparum and Plasmodium vivax malaria. Woolley SD; Marquart L; Woodford J; Chalon S; Moehrle JJ; McCarthy JS; Barber BE Malar J; 2021 Dec; 20(1):470. PubMed ID: 34930260 [TBL] [Abstract][Full Text] [Related]
15. The rise and fall of long-latency Plasmodium vivax. White NJ Trans R Soc Trop Med Hyg; 2019 Apr; 113(4):163-168. PubMed ID: 30809676 [TBL] [Abstract][Full Text] [Related]
16. Ayllon-Hermida A; Nicolau-Fernandez M; Larrinaga AM; Aparici-Herraiz I; Tintó-Font E; Llorà-Batlle O; Orban A; Yasnot MF; Graupera M; Esteller M; Popovici J; Cortés A; Del Portillo HA; Fernandez-Becerra C Front Cell Infect Microbiol; 2024; 14():1408451. PubMed ID: 38828264 [TBL] [Abstract][Full Text] [Related]
17. [The importance of the contribution of rapid test, serological and molecular methods in the diagnosis of two imported malaria cases with atypical microscopy]. Zorbozan O; Pullukçu H; Atalay Şahar E; Karakavuk M; Can H; Tunali V; Döşkaya M; Turgay N; Töz S; Özbilgin A Mikrobiyol Bul; 2017 Oct; 51(4):396-403. PubMed ID: 29153070 [TBL] [Abstract][Full Text] [Related]
18. Hypnozoite dynamics for Plasmodium vivax malaria: The epidemiological effects of radical cure. Mehra S; Stadler E; Khoury D; McCaw JM; Flegg JA J Theor Biol; 2022 Mar; 537():111014. PubMed ID: 35016895 [TBL] [Abstract][Full Text] [Related]
19. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice. Mikolajczak SA; Vaughan AM; Kangwanrangsan N; Roobsoong W; Fishbaugher M; Yimamnuaychok N; Rezakhani N; Lakshmanan V; Singh N; Kaushansky A; Camargo N; Baldwin M; Lindner SE; Adams JH; Sattabongkot J; Kappe SH Cell Host Microbe; 2015 Apr; 17(4):526-35. PubMed ID: 25800544 [TBL] [Abstract][Full Text] [Related]
20. Optimal Interruption of P. vivax Malaria Transmission Using Mass Drug Administration. Anwar MN; Hickson RI; Mehra S; Price DJ; McCaw JM; Flegg MB; Flegg JA Bull Math Biol; 2023 Apr; 85(6):43. PubMed ID: 37076740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]